Charles Dunn

Associate

Charles focuses on investment team initiatives in addition to portfolio company support.

He is a member of the biotechnology investment team, with a particular focus on new company creation. Additionally Charles is involved with ongoing fund portfolio management, due diligence of new deals, and providing operational support to existing companies in the SV portfolio.

Prior experience:
Charles qualified as an ACA after 3 years at Deloitte, with a focus on Life Sciences clients including SV portfolio companies.

Academic Credentials:
MSci Human Genetics, University College London; specialization in the genetics of neurodegenerative disease and cancer biology. Chartered accountant (ACA).

Team
Investment Team

Sector
Biotechnology

Sector Administrator
Sarah Wright (Rachel Jones)

Office
London